Related Experiment Video
Updated: Apr 27, 2026

08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
9.8K
Resolution of ambiguous HLA genotyping in korean by multi-group-specific sequence-based typing
Yongjung Park1, Cha Eun Yoon2, Oh-Joong Kwon3
1Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Medical Journal
|June 24, 2014
Summary
A new multi-group-specific sequence-based typing (SBT) method significantly reduced ambiguous human leukocyte antigen (HLA) genotyping results. This improved accuracy in HLA typing for clinical laboratories.
Area of Science:
- Immunogenetics
- Molecular Biology
- Clinical Diagnostics
Background:
- Accurate human leukocyte antigen (HLA) genotyping is crucial for transplantation and disease association studies.
- Conventional sequence-based typing (SBT) methods can yield ambiguous results, complicating interpretation.
- Resolving these ambiguities is essential for reliable HLA typing in clinical settings.
Purpose of the Study:
- To evaluate a novel multi-group-specific sequence-based typing (SBT) method.
- To assess its efficacy in resolving ambiguous genotypes for key HLA loci (HLA-A, -B, -C, and -DRB1).
Main Methods:
- Fifty samples with ambiguous genotypes from conventional SBT were re-analyzed using the AVITA plus assay, a multi-group-specific SBT method.
- Genotypes were compared, considering allele frequencies in the Korean population.
Main Results:
- The AVITA plus assay reduced the number of possible genotypes for at least one HLA locus in 96% of samples.
- Ambiguity was resolved for a significant proportion of samples across HLA-A, -B, -C, and -DRB1 loci.
- The average number of possible allele combinations per locus was substantially decreased by the AVITA plus assay.
Conclusions:
- The multi-group-specific SBT method effectively reduces ambiguous results in HLA genotyping.
- This method shows promise for enhancing the accuracy of HLA typing in clinical laboratories.

